Selective anticoagulation with active site blocked factor IXa in synthetic patch vascular repair results in decreased blood loss and operative time

ASAIO Journal

Volumn 43, Issue 5, 1997, Pages

  Spanier, Talia B ^a,b   Oz, Mehmet C ^a   Madigan, John D ^a   Rose, Eric A ^a   Stern, David M ^a   Nowygrod, Roman ^a   Schmidt, Ann Marie ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SURGERY; GRAFT COPOLYMERS; GRAFTS; HEMODYNAMICS; PATIENT TREATMENT; POLYTETRAFLUOROETHYLENES;

ANTICOAGULATION; BLOOD LOSS; HISTOLOGIC ANALYSIS; HYPERPLASIA; SYNTHETIC PATCH VASCULAR REPAIR;

BLOOD VESSEL PROSTHESES;

BLOOD CLOTTING FACTOR 9A; DACRON; HEPARIN; POLITEF;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTERY INTIMA PROLIFERATION; BLEEDING; BLOOD CLOTTING; CONFERENCE PAPER; CONTROLLED STUDY; HEMOSTASIS; NONHUMAN; RABBIT; VASCULAR SURGERY;

EID: 0031238490     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199709000-00036     Document Type: Conference Paper

References (11)

1. Adar R, Papa MZ, Amsterdam E, Bass A, Schneiderman J: Antithrombosis routines and hemorrhagic complications: a seven year survey comparing vascular and general surgical operations. J Cardiovasc Surg 26: 275-279, 1995.
2. Claggett CP, Graor RA, Salzman EW: Antithrombotic therapy in peripheral arterial occlusive disease. Chest 104: 516S-528S, 1992.
3. Dormandy J: Surgical Pharmacotherapy. Eur J Vasc Surg 3: 379-80, 1989.
4. Davies DM: A world wide survey of anticoagulation practice in clinical microvascular surgery. Br J Plast Surg 35: 96-99, 1982.
5. Connolly JE, Kwaan JHM, Brownell D, McCart PM, Levine E: Newer developments of extra anatomic bypass. Surg Gynecol Obstet 158:415-418, 1984.
6. Milne AA, Murphy WG, Reading SJ, Ruckley CV: Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomised trial. Eur J Vasc Endovasc Surg 10: 91-4, 1995.
7. Osterud B, Rapaport SI: Activation of Factor IX by the reaction product of tissue factor and Factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74: 5260-5264, 1977.
8. Braunstein KM, Noyes CM, Griffith MJ, Lundblad RL, Roberts HR: Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa. J Clin Invest 68: 1420-1426, 1981.
9. National Academy of Sciences. Guide for the Care and Use of Laboratory Animals. Bethesda, MD, U.S. Government Printing Office (NIH publication No. 85-23), 1985.
10. Benedict CR, Ryan J, Wolitzky B, et al: Active site-blocked Factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. J Clin Invest 88: 1760-1765, 1991.
11. Benedict CR, Ryan J, Todd J, et al: Active site-blocked Factor Xa prevents thrombus formation in the coronary vasculature in parallel with inhibition of extravascular coagulation in a canine thrombosis model. Blood 81: 2059-2066, 1993.